Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $66,892 | 238 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NEUROPACE, INC. | $66,892 | 238 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,696 | 143 | NEUROPACE, INC. ($39,696) |
| 2023 | $27,196 | 95 | NEUROPACE, INC. ($27,196) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $1,645.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $1,337.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $630.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $500.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $455.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $450.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $450.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $450.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $450.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $450.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $450.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $450.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: Post Approval Study • Category: Epilepsy | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Post Approval Study | NEUROPACE, INC. | $66,892 | 238 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 157 | 218 | $110,459 | $25,786 |
| 2022 | 6 | 188 | 247 | $115,213 | $28,887 |
| 2021 | 6 | 218 | 305 | $142,447 | $35,826 |
| 2020 | 3 | 90 | 153 | $79,565 | $20,670 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 54 | 110 | $73,504 | $17,306 | 23.5% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 22 | 22 | $9,614 | $2,188 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $8,161 | $1,858 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 32 | $8,887 | $1,820 | 20.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $6,181 | $1,744 | 28.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 20 | 20 | $4,112 | $870.60 | 21.2% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 71 | 115 | $70,610 | $18,337 | 26.0% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 38 | 42 | $16,842 | $4,306 | 25.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 21 | $8,148 | $2,042 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 26 | $7,228 | $1,607 | 22.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 29 | 30 | $6,210 | $1,323 | 21.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $6,175 | $1,273 | 20.6% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 81 | 148 | $91,978 | $23,761 | 25.8% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 35 | 38 | $15,333 | $3,987 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 37 | $9,963 | $2,264 | 22.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 23 | $8,456 | $2,000 | 23.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 43 | 43 | $8,901 | $1,918 | 21.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $7,816 | $1,894 | 24.2% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 43 | 101 | $63,428 | $16,647 | 26.2% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 22 | 27 | $10,962 | $2,874 | 26.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 25 | 25 | $5,175 | $1,149 | 22.2% |
About Atif Sheikh
Atif Sheikh is a Clinical Neurophysiology healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1497174353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Atif Sheikh has received a total of $66,892 in payments from pharmaceutical and medical device companies, with $39,696 received in 2024. These payments were reported across 238 transactions from 1 company. The most common payment nature is "" ($66,892).
As a Medicare-enrolled provider, Sheikh has provided services to 653 Medicare beneficiaries, totaling 923 services with total Medicare billing of $111,169. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Chapel Hill, NC
- Active Since 04/08/2014
- Last Updated 05/06/2022
- Taxonomy Code 2084N0600X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497174353
Products in Payments
- RNS Neurostimulator Kit (Device) $66,892
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.